| CTRI Number |
CTRI/2019/11/021925 [Registered on: 07/11/2019] Trial Registered Prospectively |
| Last Modified On: |
06/11/2019 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Process of Care Changes |
| Study Design |
Other |
|
Public Title of Study
|
Effect of Magnetic Stimulation in Parkinsons Disease |
|
Scientific Title of Study
|
Effect of Transcranial Magnetic Stimualtion on changes in Microel-Electrode Recording patterns
patient with Parkinsons Disease undergoing Deep Brain Stimulation: A Randomized Sham Controlled Study. |
| Trial Acronym |
TMS-DBS-MER |
|
Secondary IDs if Any
|
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Vinay Goyal |
| Designation |
Professor |
| Affiliation |
AIIMS |
| Address |
706 Dept of Neurology
CN Center AIIMS
New Delhi DELHI 110029 India |
| Phone |
|
| Fax |
|
| Email |
drvinaygoyal@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Vinay Goyal |
| Designation |
Professor |
| Affiliation |
AIIMS |
| Address |
706 Dept of Neurology
CN Center AIIMS
New Delhi DELHI 110029 India |
| Phone |
|
| Fax |
|
| Email |
drvinaygoyal@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Vinay Goyal |
| Designation |
Professor |
| Affiliation |
AIIMS |
| Address |
706 Dept of Neurology
CN Center AIIMS
New Delhi DELHI 110029 India |
| Phone |
|
| Fax |
|
| Email |
drvinaygoyal@gmail.com |
|
|
Source of Monetary or Material Support
|
| Indian Council of Medical Research
Ansari Nagar,New Delhi-110029 |
|
|
Primary Sponsor
|
| Name |
ICMR |
| Address |
ICMR Ansari Nagar New Delhi |
| Type of Sponsor |
Government funding agency |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Vinay Goyal |
AIIMS Delhi |
Dept of Neurology New Delhi DELHI |
011026594210
drvinaygoyal@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: G20||Parkinsons disease, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Real TMS |
10 Hz for 6 days |
| Comparator Agent |
Sham TMS |
The settings being used during real stimulation will be mimicked minus the actual stimulation. Thus sham stimulation will be delivered using a seperate sham coil for 6 days. |
|
|
Inclusion Criteria
|
| Age From |
45.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Both |
| Details |
1. Diagnosis of clinically definite PD, defined by UKPD brain bank clinical and diagnostic criteria. With presence of at least 1 out of 3 cardinal motor features of PD (resting tremor, rigidity, and postural impairment like bradykinesia);
2. PD patients of both gender with H&Y stage above 1 to 2.
3. PD patients between age 45 to 75 on stable medication for at least 30 days. |
|
| ExclusionCriteria |
| Details |
1. Features suggestive of other causes of Parkinsonism/ Parkinson-plus syndromes;
2. History of ICSOL (intracranial space occupying lesion) or brain surgeries, significant headaches, epilepsy or seizure disorder, mass lesions, or major head trauma leading to loss of consciousness of any length;
3. Family (1st degree relatives) history of epilepsy;
4. Presence of contraindications for functional magnetic resonance imaging (fMRI) like metal implants, and claustrophobia;
5. History of schizophrenia, schizoaffective disorder, other psychosis, rapid-cycling bipolar illness, alcohol/drug abuse within the past year;
6. Need for rapid clinical response due to conditions such as psychosis, or suicide tendency;
7. Patients with uncontrolled hypertension and diabetes and other uncontrolled medical illness. Patients with hypertension or diabetes would be included only if they are stable on medication for last six months. |
|
|
Method of Generating Random Sequence
|
Random Number Table |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant, Investigator and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| UPDRS, PDQ 39, LED, |
Day 1 and Day 6 |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| MER |
During Scheduled DBS surgery |
| resting fMRI |
Day 1 and Day 6 |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
12/11/2019 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NA |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
rTMS is known to have neuromodulatory effects in Parkinson’s Disease but the mechanisms by which the motor benefits are incurred largely remain obscure. The objective of this study is to understand the cortico-subcortical plasticity with resting fMRI and Microelectrode Recording (MER) in patients with Parkinson’s Disease (PWP). This study thus involves modulating the motor cortical areas and observe the clinical and imaging outcome and attempt to correlate with subcortical MER pattern. The subcortical MER patterns would provide a measure of status of subcortical modulation by cortical rTMS. This may provide an insight into mechanisms of rTMS palsticity. The PWP will be divided into 2 groups and clinical, motor and imaging outcomes shall be observed before and after rTMS protocol. Both the group subjects would then undergo routine Deep Brain Stimualtion surgery during which the MER will be recorded. MER will be assessed between groups with real and sham rTMS. Any changes in the MER patterns will be correlated with the changes in clinical and resting state fMRI; thus providing insight into the possible mechanisms of action rTMS in producing motor benefits. |